vs
KAISER ALUMINUM CORP（KALU）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
KAISER ALUMINUM CORP的季度营收约是Revvity的1.2倍（$929.0M vs $772.1M），Revvity净利率更高（12.7% vs 3.0%，领先9.7%），KAISER ALUMINUM CORP同比增速更快（21.4% vs 5.9%），Revvity自由现金流更多（$161.8M vs $-51.1M），过去两年KAISER ALUMINUM CORP的营收复合增速更高（12.2% vs 9.0%）
凯撒铝业是美国知名铝产品生产商，前身为凯撒铝业化工公司。其历史可追溯至Permanente Metals公司，该公司公开发行普通股后更名为凯撒铝业化工公司，后续拆分出现在的凯撒铝业，深耕铝材料生产领域，为下游多行业提供铝制品解决方案。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
KALU vs RVTY — 直观对比
营收规模更大
KALU
是对方的1.2倍
$772.1M
营收增速更快
KALU
高出15.5%
5.9%
净利率更高
RVTY
高出9.7%
3.0%
自由现金流更多
RVTY
多$212.9M
$-51.1M
两年增速更快
KALU
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $929.0M | $772.1M |
| 净利润 | $28.2M | $98.4M |
| 毛利率 | 13.3% | — |
| 营业利润率 | 6.5% | 14.5% |
| 净利率 | 3.0% | 12.7% |
| 营收同比 | 21.4% | 5.9% |
| 净利润同比 | 42.4% | 3.9% |
| 每股收益（稀释后） | $1.67 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KALURVTY
| Q4 25 | $929.0M | $772.1M | ||
| Q3 25 | $843.5M | $698.9M | ||
| Q2 25 | $823.1M | $720.3M | ||
| Q1 25 | $777.4M | $664.8M | ||
| Q4 24 | $765.4M | $729.4M | ||
| Q3 24 | $747.7M | $684.0M | ||
| Q2 24 | $773.4M | $691.7M | ||
| Q1 24 | $737.5M | $649.9M |
净利润KALURVTY
| Q4 25 | $28.2M | $98.4M | ||
| Q3 25 | $39.5M | $46.7M | ||
| Q2 25 | $23.2M | $53.9M | ||
| Q1 25 | $21.6M | $42.2M | ||
| Q4 24 | $19.8M | $94.6M | ||
| Q3 24 | $8.8M | $94.4M | ||
| Q2 24 | $18.9M | $55.4M | ||
| Q1 24 | $18.2M | $26.0M |
毛利率KALURVTY
| Q4 25 | 13.3% | — | ||
| Q3 25 | 13.6% | 53.6% | ||
| Q2 25 | 12.2% | 54.5% | ||
| Q1 25 | 13.4% | 56.5% | ||
| Q4 24 | 12.5% | — | ||
| Q3 24 | 9.6% | 56.3% | ||
| Q2 24 | 13.4% | 55.7% | ||
| Q1 24 | 11.7% | 54.6% |
营业利润率KALURVTY
| Q4 25 | 6.5% | 14.5% | ||
| Q3 25 | 5.8% | 11.7% | ||
| Q2 25 | 4.6% | 12.6% | ||
| Q1 25 | 5.3% | 10.9% | ||
| Q4 24 | 5.0% | 16.3% | ||
| Q3 24 | 1.8% | 14.3% | ||
| Q2 24 | 4.7% | 12.4% | ||
| Q1 24 | 3.3% | 6.8% |
净利率KALURVTY
| Q4 25 | 3.0% | 12.7% | ||
| Q3 25 | 4.7% | 6.7% | ||
| Q2 25 | 2.8% | 7.5% | ||
| Q1 25 | 2.8% | 6.4% | ||
| Q4 24 | 2.6% | 13.0% | ||
| Q3 24 | 1.2% | 13.8% | ||
| Q2 24 | 2.4% | 8.0% | ||
| Q1 24 | 2.5% | 4.0% |
每股收益（稀释后）KALURVTY
| Q4 25 | $1.67 | $0.86 | ||
| Q3 25 | $2.38 | $0.40 | ||
| Q2 25 | $1.41 | $0.46 | ||
| Q1 25 | $1.31 | $0.35 | ||
| Q4 24 | $1.21 | $0.77 | ||
| Q3 24 | $0.54 | $0.77 | ||
| Q2 24 | $1.15 | $0.45 | ||
| Q1 24 | $1.12 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.0M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $826.1M | $7.3B |
| 总资产 | $2.6B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KALURVTY
| Q4 25 | $7.0M | $919.9M | ||
| Q3 25 | $17.2M | $931.4M | ||
| Q2 25 | $13.1M | $991.8M | ||
| Q1 25 | $21.3M | $1.1B | ||
| Q4 24 | $18.4M | $1.2B | ||
| Q3 24 | $45.7M | $1.2B | ||
| Q2 24 | $70.4M | $2.0B | ||
| Q1 24 | $101.6M | $1.7B |
股东权益KALURVTY
| Q4 25 | $826.1M | $7.3B | ||
| Q3 25 | $806.1M | $7.4B | ||
| Q2 25 | $776.0M | $7.6B | ||
| Q1 25 | $756.8M | $7.6B | ||
| Q4 24 | $743.1M | $7.7B | ||
| Q3 24 | $729.4M | $7.9B | ||
| Q2 24 | $727.6M | $7.9B | ||
| Q1 24 | $714.7M | $7.8B |
总资产KALURVTY
| Q4 25 | $2.6B | $12.2B | ||
| Q3 25 | $2.6B | $12.1B | ||
| Q2 25 | $2.5B | $12.4B | ||
| Q1 25 | $2.4B | $12.4B | ||
| Q4 24 | $2.4B | $12.4B | ||
| Q3 24 | $2.3B | $12.8B | ||
| Q2 24 | $2.3B | $13.4B | ||
| Q1 24 | $2.3B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.6M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $-51.1M | $161.8M |
| 自由现金流率自由现金流/营收 | -5.5% | 21.0% |
| 资本支出强度资本支出/营收 | 3.3% | 2.6% |
| 现金转化率经营现金流/净利润 | -0.73× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $-25.5M | $509.4M |
8季度趋势，按日历期对齐
经营现金流KALURVTY
| Q4 25 | $-20.6M | $182.0M | ||
| Q3 25 | $59.1M | $138.5M | ||
| Q2 25 | $15.9M | $134.3M | ||
| Q1 25 | $57.0M | $128.2M | ||
| Q4 24 | $43.4M | $174.2M | ||
| Q3 24 | $34.1M | $147.9M | ||
| Q2 24 | $26.3M | $158.6M | ||
| Q1 24 | $63.3M | $147.6M |
自由现金流KALURVTY
| Q4 25 | $-51.1M | $161.8M | ||
| Q3 25 | $34.5M | $120.0M | ||
| Q2 25 | $-27.7M | $115.5M | ||
| Q1 25 | $18.8M | $112.2M | ||
| Q4 24 | $-12.6M | $149.8M | ||
| Q3 24 | $-17.0M | $125.6M | ||
| Q2 24 | $-17.4M | $136.6M | ||
| Q1 24 | $33.3M | $129.7M |
自由现金流率KALURVTY
| Q4 25 | -5.5% | 21.0% | ||
| Q3 25 | 4.1% | 17.2% | ||
| Q2 25 | -3.4% | 16.0% | ||
| Q1 25 | 2.4% | 16.9% | ||
| Q4 24 | -1.6% | 20.5% | ||
| Q3 24 | -2.3% | 18.4% | ||
| Q2 24 | -2.2% | 19.7% | ||
| Q1 24 | 4.5% | 20.0% |
资本支出强度KALURVTY
| Q4 25 | 3.3% | 2.6% | ||
| Q3 25 | 2.9% | 2.6% | ||
| Q2 25 | 5.3% | 2.6% | ||
| Q1 25 | 4.9% | 2.4% | ||
| Q4 24 | 7.3% | 3.4% | ||
| Q3 24 | 6.8% | 3.3% | ||
| Q2 24 | 5.7% | 3.2% | ||
| Q1 24 | 4.1% | 2.7% |
现金转化率KALURVTY
| Q4 25 | -0.73× | 1.85× | ||
| Q3 25 | 1.50× | 2.97× | ||
| Q2 25 | 0.69× | 2.49× | ||
| Q1 25 | 2.64× | 3.03× | ||
| Q4 24 | 2.19× | 1.84× | ||
| Q3 24 | 3.88× | 1.57× | ||
| Q2 24 | 1.39× | 2.87× | ||
| Q1 24 | 3.48× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KALU
| Packaging | $440.6M | 47% |
| Aero Hs Products | $213.0M | 23% |
| Transferred Over Time | $200.2M | 22% |
| Automotive Extrusions | $75.4M | 8% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
